UCB offers support to people living with chronic diseases, along with their families and friends, through a broad range of programs that foster independence and empowerment.  The UCB Family Scholarship Program™ is just one such program; for information on others, visit www.UCB-usa.com/patients.

About Rheumatoid ArthritisRheumatoid arthritis (RA) affects more than 1.3 million Americans, and it is estimated that 5 million people suffer from RA globally. Prevalence is not split evenly between genders, since women are three times more likely to be affected than men. Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.For Further Information:Bert Kelly, Communications and Public Relations Manager, UCBT: 770.970.8491, Bert.Kelly@ucb.comAbout UCBUCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8 000 people in about 40 countries, the company generated revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB).